Effects on Lipoprotein Subclasses of Combined Expression of Human Hepatic Lipase and Human apoB in Transgenic Rabbits

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 24, Issue 1, 2004, Pages 141-146

  Rizzo, Manfredi ^a,b   Taylor, John M ^c   Barbagallo, Carlo M ^b   Berneis, Kaspar ^d   Blanche, Patricia J ^a   Krauss, Ronald M ^a,e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d University Hospital Bruderholz   (Switzerland)

^e CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

apoB; Density gradient ultracentrifugation; Hepatic lipase; LDL; Rabbit; Transgene

Indexed keywords

APOLIPOPROTEIN B; LIPOPROTEIN; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ARTICLE; DENSITOMETRY; DENSITY GRADIENT CENTRIFUGATION; GEL ELECTROPHORESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABBIT; TRANSGENIC ANIMAL;

ANIMAL FEED; ANIMALS; ANIMALS, GENETICALLY MODIFIED; APOLIPOPROTEINS B; CENTRIFUGATION, DENSITY GRADIENT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HUMANS; LIPASE; LIPOPROTEINS, LDL; MOLECULAR WEIGHT; RABBITS; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY; SPECIFIC PATHOGEN-FREE ORGANISMS; TRIGLYCERIDES;

EID: 0346492593     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000107027.73816.ce     Document Type: Article

References (38)

1. Sanan DA, Fan J, Bensadoun A, Taylor JM. Hepatic lipase is abundant on both hepatocyte and endothelial cell surfaces in the liver. J Lipid Res. 1997;38:1002-1013.
2. Doolittle MH, Wong H, Davis RC, Schotz MC. Synthesis of hepatic lipase in liver and extrahepatic tissues. J Lipid Res. 1987;28:1326-1334.
3. Jansen H, Hulsmann WC. Enzymology and physiological role of hepatic lipase. Biochem Soc Trans. 1985;13:24-26.
4. Ji Z-S, Lauer SJ, Fazio S, Bensadoun A, Taylor JM, Mahley RM. Enhanced binding and uptake of remnant lipoproteins by hepatic lipase-secreting hepatoma cells in culture. J Biol Chem. 1994;269:13429-13436.
5. Auwerx JH, Marzetta CA, Hokanson JE, Brunzell JD. Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis. 1989;9:319-325.
6. Breckenridge WC, Little JA, Alaupovic P, Wang CS, Kuksis A, Kakis G, Lindgren F, Gardiner G. Lipoprotein abnormalities associated with a familial deficiency of hepatic lipase. Atherosclerosis. 1982;45:161-179.
7. Hegele RA, Little JA, Vezina C, Maguire GF, Tu L, Wolever TS, Jenkins DJ, Connelly PW. Hepatic lipase deficiency: clinical, biochemical, and molecular genetic characteristics. Arterioscl Thromb Vasc Biol. 1993;13:720-728.
8. Demant T, Carlson LA, Holmquist L, Karpe F, Nilsson-Ehle P, Packard CJ, Shepherd J. Lipoprotein metabolism in hepatic lipase deficiency: studies on the turnover of apolipoprotein B and on the effect of hepatic lipase on high density lipoprotein. J Lipid Res. 1988;29:1603-1161.
9. Qiu S, Bergeron N, Kotite L, Krauss RM, Bensadoun A, Havel RJ. Metabolism of lipoproteins containing apolipoprotein B in hepatic lipase-deficient mice. J Lipid Res. 1998;39:1661-1668.
10. Brousseau ME, Hoeg JM. Transgenic rabbits as models for atherosclerosis research. J Lipid Res. 1999;40:365-375.
11. Fan J, Wang J, Bensadoun A, Lauer DJ, Dang Q, Mahley RM, Taylor JM. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high-density lipoproteins and intermediate density lipoproteins. Proc Natl Acad Sci U S A. 1994;91:8724-8728.
12. Barbagallo CM, Fan J, Blanche PJ, Rizzo M, Taylor JM, Krauss RM. Overexpression of human hepatic lipase and apoprotein E in transgenic rabbits attenuates response to dietary cholesterol and alters lipoprotein subclass distributions. Arterioscl Thromb Vasc Biol. 1999;19:625-632.
13. Fan J, McCormick SPA, Krauss RM, Taylor S, Quan R, Taylor JM, Young SG. Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL. Arterioscl Thromb Vasc Biol. 1995;15:1889-1899.
14. Lindgren FT, Jensen LC, Hatch FT. The isolation and quantitative analysis of lipoproteins. In: Nelson GJ, ed. Blood Lipids and Lipoproteins: Quantitation, Composition and Metabolism. New York, NY: Wiley-Interscience. 1972:181-274.
15. Shen MS, Krauss RM, Lindgren FT, Forte TM. Heterogeneity of serum low-density lipoproteins in normal human subjects. J Lipid Res. 1981;22:236-244.
16. Musliner TA, Giotas C, Krauss RM. Presence of multiple subpopulations of lipoproteins of intermediate density in normal subjects. Arteriosclerosis. 1986;6:79-87.
17. Krauss RM, Burke DJ. Identification of multiple subclasses of plasma low-density lipoproteins in normal humans. J Lipid Res. 1982;23:97-104.
18. Nichols AV, Krauss RM, Musliner TA. Nondenaturing polyacrylamide gradient gel electrophoresis. In: Segrest JP, Albers JJ, eds. Methods in Enzymology: Plasma Lipoproteins. New York, NY: Academic Press. 1986:417-431.
19. Rainwater DL, Andres DW, Ford AL, Lowe F, Blanche PJ, Krauss RM. Production of polyacrylamide gradient gels for the electrophoretic resolution of lipoproteins. J Lipid Res. 1992;33:1876-1881.
20. Allain CC, Poon, LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20:470-475.
21. Nagele U, Hagele EO, Sauer G, Wiedemann E, Lehmann P, Wahlefeld AW, Gruber W. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984;22:165-174.
22. Warnick GR, Nguyen T, Albers JJ. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem. 1985;31:217-222.
23. Markell MAK, Haas SM, Bieber LL, Tolert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87:206-210.
24. Zambon A, Deeb SS, Pauletto P, Crepaldi G, Brunzell JD. Hepatic lipase: a market for cardiovascular disease risk and response to therapy. Curr Opin Lipidol. 2003;14:179-189.
25. Cohen JC, Vega GL, Grundy SM. Hepatic lipase: new insights from genetic and metabolic studies. Curr Opin Lipidol. 1999;10:259-267.
26. Zambon A, Austin MA, Brown BG, Hokanson JE, Brunzell JD. Effect of hepatic lipase on LDL in normal men and those with coronary artery disease. Arterioscl Thromb Vasc Biol. 1993;13:147-153.
27. Campos H, Dreon DM, Krauss RM. Associations of hepatic and lipoprotein lipase activities with changes in dietary composition and low-density lipoprotein subclasses. J Lipid Res. 1995;36:462-472.
28. Sultan FD, Lagrange D, Le Liepvre X, Griglio S. Inhibition of hepatic lipase impairs chylomicron remnant-removal in rats. Biochim Biophys Acta. 1989;1042:150-152.
29. Homanics GE, de Silva HV, Osada J, Zhang SH, Wong H, Borensztajn J, Maeda N. Mild dyslipidemia in mice following targeted inactivation of the hepatic lipase gene. J Biol Chem. 1995;270:2974-2980.
30. Braschi S, Couture N, Gambarotta A, Gauthier BR, Coffill CR, Sparks DL, Maeda N, Schultz JR. Hepatic lipase affects both HDL and ApoB-containing lipoprotein levels in the mouse. Biochim Biophys Acta. 1998;1392:276-290.
31. Dichek HL, Brecht W, Fan F, Ji ZS, McCormick SP, Akeefe H, Conzo L, Sanan DA, Weisgraber KH, Young SG, Taylor JM, Mahley RW. Overexpression of hepatic lipase in transgenic mice decreases apolipoprotein B-containing and high-density lipoproteins. Evidence that hepatic lipase acts as a ligand for lipoprotein uptake. J Biol Chem. 1998;273:1896-1903.
32. Dichek HL, Johnson SM, Akeefe H, Lo GT, Sage E, Yap CE, Mahley RW. Hepatic lipase overexpression lowers remnant and LDL levels by a noncatalytic mechanism in LDL receptor-deficient mice. J Lipid Res. 2001;42:201-210.
33. Choi SY, Goldberg IJ, Curtiss LK, Cooper AD. Interaction between ApoB and hepatic lipase mediates the uptake of ApoB-containing lipoproteins. J Biol Chem. 1998;273:20456-20462.
34. Zambon A, Deeb SS, Bensadoun A, Foster KE, Brunzell JD. In vivo evidence of a role for hepatic lipase in human apoB-containing lipoprotein metabolism, independent of its lipolytic activity. J Lipid Res. 2000;41:2094-2099.
35. Dugi KA, Arnar MJ, Haudenschild CC, Shamburek RD, Bensadoun A, Hoyt RF, Fruchart-Najib J, Madj Z, Brewer HB, Santamarina-Fojo S. In vivo evidence for both lipolytic and nonlipolytic function of hepatic lipase in the metabolism of HDL. Arterioscl Thromb Vasc Biol. 2000;20:793-800.
36. Jansen H, Verhoeven AJ, Sijbrands EJ. Hepatic lipase: a pro- or anti-atherogenic protein? J Lipid Res. 2002;43:1352-1362.
37. Zambon A, Hokanson JE, Brown BG, Brunzell JD. Evidence for a new pathophysiological mechanism for coronary artery disease regression: hepatic lipase-mediated changes in LDL density. Circulation. 1999;99:1959-1964.
38. Hoeg JM, Santamarina-Fojo S, Berard AM, Comhill JF, Herderick EE, Feldman SH, Haudenschild CC, Vaisman BL, Hoyt RF, Demosky SJ, Kauffman RD, Hazel CM, Marcovina SM, Brewer HB. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc Natl Acad Sci U S A. 1996;93:11448-11453.